{"meta":{"query_hash":"6eb7f29437b7","filters":{"venue":"Prostate International"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6eb7f29437b7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Prostate+International"},"results":[{"id":"W2792049128","doi":"10.1016/j.prnil.2018.03.002","title":"Is prostate specific antigen (PSA) density necessary in selecting prostate cancer patients for active surveillance and what should be the cutoff in the Asian population?","year":2018,"lang":"en","type":"article","venue":"Prostate International","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Prostate-specific antigen; Pathological; Receiver operating characteristic; Adverse effect; Cancer; Cohort; Oncology; Internal medicine; Urology; Cutoff","score_opus":0.034589263984855505,"score_gpt":0.3346653812258444,"score_spread":0.30007611724098887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792049128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941301,0.0025965304,0.000668274,0.0012166142,0.000059214515,0.000022968732,0.00018654126,0.000011126396,0.0011085318],"genre_scores_gemma":[0.99907804,0.00027768392,0.00036588043,0.00009917095,0.000037241494,0.000009124297,0.00009594733,0.0000022575368,0.000034569875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998486,0.0007002205,0.0002355685,0.0001693138,0.0002653642,0.00014364353],"domain_scores_gemma":[0.9930688,0.0026660108,0.0022891734,0.000375759,0.00081377313,0.0007864804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053731417,0.0002860637,0.0005756612,0.0007051969,0.00031509995,0.0009811649,0.0006817007,0.0006848759,0.0010070321],"category_scores_gemma":[0.013503897,0.00017212883,0.0003966463,0.0012481409,0.0008985068,0.00091871206,0.00037467398,0.00055271597,0.00029915254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013402138,0.00001827098,0.9946043,0.00002165879,0.000027082786,0.000030600266,0.000044945813,0.00005020643,0.00011313081,0.000028620676,0.00012059204,0.004806529],"study_design_scores_gemma":[0.000026780248,0.00038676537,0.9952957,0.00009265202,0.00016702466,0.00068467826,0.0007739543,0.000974585,0.0004650795,0.0003089388,0.0008120983,0.000011749573],"about_ca_topic_score_codex":0.0025527452,"about_ca_topic_score_gemma":0.0034064243,"teacher_disagreement_score":0.0053731417,"about_ca_system_score_codex":0.0005650936,"about_ca_system_score_gemma":0.0014478789,"threshold_uncertainty_score":0.028416216},"labels":[],"label_agreement":null},{"id":"W4210316818","doi":"10.1016/j.prnil.2022.01.004","title":"Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer","year":2022,"lang":"en","type":"article","venue":"Prostate International","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Biopsy; Prostate cancer; Logistic regression; Prostate biopsy; Core (optical fiber); Cancer; Stage (stratigraphy); Core biopsy; Internal medicine; Surgery; Urology; Breast cancer","score_opus":0.01860648074195801,"score_gpt":0.29249639592186844,"score_spread":0.2738899151799104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210316818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989512,0.00044301242,0.00012855636,0.000021196705,0.0000064529945,0.0000053628582,0.00017341634,0.0000053749013,0.00026538962],"genre_scores_gemma":[0.99959356,0.00007088678,0.000050050236,0.000009736059,0.0000047029257,0.0000014623732,0.00022316826,0.0000017731813,0.00004468084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991737,0.00023800822,0.00007673549,0.00018915413,0.00013800143,0.00018431355],"domain_scores_gemma":[0.9978491,0.0004968464,0.000866649,0.0003231471,0.00015198716,0.0003121463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010811136,0.00029573767,0.0003635327,0.0008117723,0.00022243694,0.00067405275,0.00047934498,0.00030609305,0.0013217995],"category_scores_gemma":[0.0043976656,0.00026760498,0.0010370575,0.00076909794,0.00029239134,0.00046819882,0.0007221833,0.0006011125,0.00021028671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016797593,0.000010746467,0.9975147,0.000011576421,0.000046145436,0.00006366194,0.000018022416,0.000069100024,0.00017309168,0.0000165555,0.000063783475,0.0018446727],"study_design_scores_gemma":[0.000005525782,0.00007593167,0.9984706,0.000008627072,0.0000770173,0.00043589377,0.000058134716,0.0005298962,0.00015063073,0.000056299585,0.00012620405,0.000005353831],"about_ca_topic_score_codex":0.003998895,"about_ca_topic_score_gemma":0.007915027,"teacher_disagreement_score":0.003998895,"about_ca_system_score_codex":0.00023871302,"about_ca_system_score_gemma":0.0002852831,"threshold_uncertainty_score":0.00795126},"labels":[],"label_agreement":null},{"id":"W4389266080","doi":"10.1016/j.prnil.2023.11.004","title":"Risks and side effects in the medical management of benign prostatic hyperplasia","year":2023,"lang":"en","type":"review","venue":"Prostate International","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Desmopressin; Side effect (computer science); Pharmacotherapy; Lower urinary tract symptoms; Hyperplasia; Urology; Intensive care medicine; Quality of life (healthcare); cGMP-specific phosphodiesterase type 5; Gynecology; Internal medicine; Erectile dysfunction; Prostate","score_opus":0.1233222919365214,"score_gpt":0.4559810165591553,"score_spread":0.3326587246226339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389266080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014170518,0.9989661,0.000056319892,0.00013151423,0.00008131509,0.000004357652,0.000016112392,0.0000034944665,0.00059894496],"genre_scores_gemma":[0.0009572138,0.9982287,0.00016612638,0.00016395,0.00012093019,0.000006740565,0.000021265716,0.0000010956915,0.00033389867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995161,0.000113162176,0.00009893099,0.00004628514,0.00020001006,0.000025522255],"domain_scores_gemma":[0.99936444,0.00041074364,0.00011448679,0.0000090644235,0.000083400046,0.000017929851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005321187,0.0006319393,0.0012642967,0.0017667079,0.0002662691,0.000886148,0.0005029735,0.00081226096,0.0038206344],"category_scores_gemma":[0.0012537881,0.00022834311,0.00088695524,0.0015183418,0.0003058565,0.00072332565,0.0004712011,0.0011836726,0.0009112253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095157906,0.00006345494,0.00037741894,0.045935355,0.00023641848,0.00040256348,0.00011774833,0.000260266,0.00092555385,0.0015006183,0.016501041,0.93358445],"study_design_scores_gemma":[0.00004300258,0.00021962741,0.0034470262,0.029980822,0.00083533657,0.0065064244,0.00018082796,0.00014697228,0.00063470023,0.0020238876,0.9559385,0.000042854586],"about_ca_topic_score_codex":0.0009451524,"about_ca_topic_score_gemma":0.0019602785,"teacher_disagreement_score":0.0038206344,"about_ca_system_score_codex":0.00040194247,"about_ca_system_score_gemma":0.0007903719,"threshold_uncertainty_score":0.012781262},"labels":[],"label_agreement":null},{"id":"W4389688076","doi":"10.1016/j.prnil.2023.12.001","title":"High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group","year":2023,"lang":"en","type":"article","venue":"Prostate International","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Enucleation; Prostate; Lower urinary tract symptoms; Urology; International Prostate Symptom Score; Urinary retention; Surgery; Bladder outlet obstruction; Prostate cancer; Transurethral resection of the prostate; Odds ratio; Internal medicine; Cancer","score_opus":0.01741993864668499,"score_gpt":0.2813165768339399,"score_spread":0.2638966381872549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389688076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808097,0.0016142017,0.000063713924,0.0000307183,0.000014018135,0.000021433218,0.000058280864,0.000001392402,0.00011533659],"genre_scores_gemma":[0.9989367,0.0005783077,0.000098571145,0.00007616065,0.000041924308,0.000030289702,0.00016630035,0.0000016994426,0.00007002504],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99934775,0.00027771515,0.00008917248,0.000117739,0.00009443513,0.000073093324],"domain_scores_gemma":[0.99839205,0.0006316698,0.0005412234,0.00010276607,0.00006807013,0.00026418807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014000016,0.00031895353,0.00096742326,0.0002965429,0.0002119393,0.00054913334,0.0003099529,0.0005439241,0.0009069372],"category_scores_gemma":[0.0018246659,0.00022316982,0.0017414885,0.0004281103,0.00027712746,0.00051410444,0.00033361066,0.00047935548,0.00013824129],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12837933,0.0019722963,0.8285004,0.0004302654,0.004076322,0.0003531236,0.0002723271,0.00039835347,0.0024989438,0.000071717404,0.0005506439,0.03249636],"study_design_scores_gemma":[0.012982472,0.03274856,0.9469302,0.00009869755,0.0035640227,0.0008808737,0.00040129205,0.00088072167,0.00059686345,0.00012561891,0.00074166217,0.000048957245],"about_ca_topic_score_codex":0.0005686854,"about_ca_topic_score_gemma":0.0013793862,"teacher_disagreement_score":0.0014000016,"about_ca_system_score_codex":0.00033629715,"about_ca_system_score_gemma":0.00039946797,"threshold_uncertainty_score":0.0074040294},"labels":[],"label_agreement":null},{"id":"W4404367273","doi":"10.1016/j.prnil.2024.11.001","title":"Concurrent antiandrogen therapy in the salvage radiotherapy setting for recurrent prostate cancer: a literature review","year":2024,"lang":"en","type":"review","venue":"Prostate International","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salvage therapy; Prostate cancer; Radiation therapy; Antiandrogen; Recurrent prostate cancer; Prostatectomy; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.06130048351684187,"score_gpt":0.45614122306571303,"score_spread":0.39484073954887117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404367273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009284623,0.999511,0.000025014258,0.00008981723,0.000043152024,0.000008666654,0.00002610007,0.0000018738664,0.00020148125],"genre_scores_gemma":[0.0005098031,0.99923825,0.00006565148,0.00007972936,0.000036682693,0.00000694236,0.000019765534,5.017268e-7,0.00004263826],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995546,0.0000901035,0.00015963179,0.00006354318,0.00011096467,0.000021143771],"domain_scores_gemma":[0.9979978,0.0013887396,0.00033781183,0.000027427874,0.0002087402,0.000039404527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010077487,0.00078441284,0.0020503718,0.0044942903,0.0003327321,0.0011664757,0.0011092874,0.00088851916,0.0052315085],"category_scores_gemma":[0.0031056996,0.00033221795,0.0016514512,0.0052258587,0.00037688838,0.0012360469,0.00056043826,0.00083078013,0.0006155584],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015073539,0.000066133995,0.0004567186,0.39349383,0.0010309907,0.00030784198,0.00016181527,0.0002539303,0.00047300654,0.0011700796,0.014678823,0.5877561],"study_design_scores_gemma":[0.00012858544,0.00034893633,0.005163862,0.39460826,0.011953698,0.004614885,0.00037670176,0.00017740375,0.0005053257,0.0020104875,0.5800424,0.00006943991],"about_ca_topic_score_codex":0.0026093158,"about_ca_topic_score_gemma":0.005966035,"teacher_disagreement_score":0.0052315085,"about_ca_system_score_codex":0.00068970094,"about_ca_system_score_gemma":0.002966973,"threshold_uncertainty_score":0.017501116},"labels":[],"label_agreement":null},{"id":"W4412435884","doi":"10.1016/j.prnil.2025.07.002","title":"Advances in focal therapy for prostate cancer: current modalities, outcomes, and future directions","year":2025,"lang":"en","type":"article","venue":"Prostate International","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Modalities; Treatment modality; Medical physics; Current (fluid); Therapeutic modalities; Cancer; Intensive care medicine; Internal medicine","score_opus":0.013600582574124758,"score_gpt":0.350079016046935,"score_spread":0.3364784334728102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412435884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044600922,0.99500483,0.0006393901,0.00244982,0.000171738,0.000008521133,0.000024365738,0.000019579093,0.001235741],"genre_scores_gemma":[0.0053894217,0.9913544,0.0011585833,0.0011206731,0.0005061809,0.000019554871,0.00005780869,0.000009697669,0.0003837094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991436,0.00024456554,0.00011938741,0.00012901449,0.00026900056,0.000094525756],"domain_scores_gemma":[0.9969042,0.0018454568,0.0003177086,0.00009862909,0.00066092564,0.00017316219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034661088,0.0006269702,0.0012006732,0.0015600243,0.0004005013,0.0020677762,0.0009572141,0.0013300742,0.0052282615],"category_scores_gemma":[0.003389416,0.0002071516,0.0009721211,0.0015758444,0.0012325036,0.0029063937,0.0010140631,0.0024421006,0.0012940518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020894274,0.00013044078,0.00080093794,0.010752103,0.00010894828,0.00017022893,0.00011780714,0.0005424717,0.001994197,0.009286477,0.0150755895,0.96081185],"study_design_scores_gemma":[0.000072218034,0.0010400777,0.0035283405,0.0115404865,0.0005156401,0.0025616353,0.00046737434,0.0008690463,0.003273917,0.016244583,0.9597888,0.00009785843],"about_ca_topic_score_codex":0.0013094896,"about_ca_topic_score_gemma":0.002397269,"teacher_disagreement_score":0.0052282615,"about_ca_system_score_codex":0.0012392133,"about_ca_system_score_gemma":0.0022965774,"threshold_uncertainty_score":0.018330812},"labels":[],"label_agreement":null},{"id":"W4415751873","doi":"10.1016/j.prnil.2025.10.002","title":"Quality-of-life outcomes following Aquablation in men with poor initial quality of life: pooled analysis of five international studies","year":2025,"lang":"en","type":"article","venue":"Prostate International","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; BP (Canada); University of Toronto","funders":"","keywords":"Quality of life (healthcare); Logistic regression; Pooled analysis; Sexual function; Clinical trial; International Prostate Symptom Score; Psychological intervention; Prostate cancer","score_opus":0.07965961175546782,"score_gpt":0.46366481750524313,"score_spread":0.3840052057497753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415751873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64609253,0.3407461,0.0035005608,0.00024973848,0.00016379493,0.0003356827,0.007057371,0.00007921557,0.0017750505],"genre_scores_gemma":[0.97067666,0.023315236,0.0009777463,0.00019230999,0.000172987,0.00028300515,0.004259272,0.000021965414,0.00010086731],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98611176,0.007251039,0.003171981,0.0017148345,0.0014777989,0.00027268054],"domain_scores_gemma":[0.9603388,0.019332765,0.01506928,0.0024435082,0.002378827,0.00043683153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020334845,0.0013309283,0.0050308714,0.007759494,0.0003251756,0.00243155,0.00074268656,0.00087814,0.00078393274],"category_scores_gemma":[0.031952113,0.0006466977,0.012719055,0.00714355,0.0006151977,0.0010785501,0.0017209919,0.00049351464,0.000103099075],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007231297,0.00006316474,0.67486244,0.011804779,0.2709038,0.00014372765,0.00029573904,0.0009114665,0.00048892974,0.000083232306,0.0004999669,0.032711435],"study_design_scores_gemma":[0.0008460883,0.0015587909,0.7678978,0.0023795587,0.22284025,0.0005876779,0.00039194705,0.00056783855,0.00037178336,0.00018801253,0.0022737565,0.00009647148],"about_ca_topic_score_codex":0.0014068157,"about_ca_topic_score_gemma":0.0022237815,"teacher_disagreement_score":0.020334845,"about_ca_system_score_codex":0.00047930432,"about_ca_system_score_gemma":0.00049196446,"threshold_uncertainty_score":0.10754222},"labels":[],"label_agreement":null},{"id":"W4416021469","doi":"10.1016/j.prnil.2025.11.001","title":"Irreversible electroporation in focal therapy for prostate cancer: current status and future directions","year":2025,"lang":"en","type":"article","venue":"Prostate International","topic":"Microbial Inactivation Methods","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; NOSM University; McGill University Health Centre","funders":"","keywords":"Irreversible electroporation; Prostate cancer; Prostate; Ablative case; Neurovascular bundle; Prostatectomy; Ablation; Erectile function","score_opus":0.010312474473598201,"score_gpt":0.34201841837900976,"score_spread":0.3317059439054116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416021469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005545917,0.9951845,0.00086701824,0.002003706,0.0001683921,0.000009414109,0.0000123247455,0.000020348383,0.0011797532],"genre_scores_gemma":[0.0044353115,0.99275815,0.0012066807,0.0008295733,0.00029983983,0.000023277007,0.000025956782,0.000007460953,0.00041367064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993325,0.00023716073,0.00007188735,0.00009817574,0.00017735892,0.00008292099],"domain_scores_gemma":[0.99747294,0.001752236,0.0002446755,0.00006652158,0.00036143453,0.00010211377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044127856,0.00054230384,0.0011723941,0.00097175344,0.00035216892,0.0018509368,0.0010193839,0.001732031,0.0038138416],"category_scores_gemma":[0.0024240399,0.00030007114,0.0007761669,0.0012021358,0.0015709065,0.0027911284,0.0008920935,0.0022645171,0.0011408204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025619406,0.00019444547,0.0005023662,0.010071126,0.00007944458,0.0001380472,0.00015200753,0.00097481575,0.0042484426,0.009437436,0.010075483,0.9638702],"study_design_scores_gemma":[0.00010272111,0.0016396332,0.002513041,0.009752309,0.00039660398,0.0012795258,0.0005082765,0.0012636484,0.0063126716,0.019875253,0.9562489,0.00010749465],"about_ca_topic_score_codex":0.0014972605,"about_ca_topic_score_gemma":0.0027177306,"teacher_disagreement_score":0.0044127856,"about_ca_system_score_codex":0.0010869767,"about_ca_system_score_gemma":0.0021522248,"threshold_uncertainty_score":0.023337305},"labels":[],"label_agreement":null}]}